GLENMARK PHARMACEUTICALS
|
GLENMARK PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,399 Cr | ₹569 Cr | ₹868 Cr | ₹1,441 Cr | ₹1,382 Cr |
| Adjustment | ₹982 Cr | ₹1,010 Cr | ₹1,472 Cr | ₹787 Cr | ₹645 Cr |
| Changes In working Capital | ₹-2,529 Cr | ₹-797 Cr | ₹-1,074 Cr | ₹-561 Cr | ₹-386 Cr |
| Cash Flow after changes in Working Capital | ₹-147 Cr | ₹782 Cr | ₹1,266 Cr | ₹1,667 Cr | ₹1,641 Cr |
| Cash Flow from Operating Activities | ₹-828 Cr | ₹-265 Cr | ₹625 Cr | ₹1,109 Cr | ₹1,131 Cr |
| Cash Flow from Investing Activities | ₹2.09 Cr | ₹4,561 Cr | ₹-528 Cr | ₹-333 Cr | ₹-675 Cr |
| Cash Flow from Financing Activities | ₹787 Cr | ₹-3,906 Cr | ₹-77 Cr | ₹-520 Cr | ₹-442 Cr |
| Net Cash Inflow / Outflow | ₹-38 Cr | ₹389 Cr | ₹19 Cr | ₹255 Cr | ₹14 Cr |
| Opening Cash & Cash Equivalents | ₹1,658 Cr | ₹1,443 Cr | ₹1,411 Cr | ₹1,138 Cr | ₹1,110 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | ₹0.67 Cr | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | ₹-192 Cr | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹56 Cr | ₹18 Cr | ₹12 Cr | ₹18 Cr | ₹14 Cr |
| Closing Cash & Cash Equivalent | ₹1,676 Cr | ₹1,658 Cr | ₹1,443 Cr | ₹1,411 Cr | ₹1,138 Cr |
Compare Cashflow Statement of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹58,542.4 Cr | 1.9% | 5.5% | 24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,319.0 Cr | 2.4% | -2.5% | -7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,383.0 Cr | 3.9% | 2.6% | 3.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,241.0 Cr | 2.5% | 4.1% | 12.3% | Stock Analytics | |
| CIPLA | ₹123,617.0 Cr | 1.3% | 0.6% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,825.0 Cr | -1.2% | -1.5% | -9.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1.9% |
5.5% |
24.4% |
| SENSEX | 0.5% |
-0.2% |
8.4% |
You may also like the below Video Courses